Neonatal Hypoglycaemia: A Never-Ending Story?

Area of Science:

• Neonatology
• Pediatric Endocrinology
• Neurodevelopmental Pediatrics

Background:

• Neonatal hypoglycemia is a frequent metabolic disorder in newborns, posing a risk for brain injury.
• Current diagnostic and management approaches lack universal consensus, leading to challenges in identifying at-risk infants.
• Nonspecific symptoms and varying glucose thresholds complicate timely and appropriate intervention.

Purpose of the Study:

• To provide a comprehensive overview of neonatal hypoglycemia, from its physiological basis to therapeutic interventions.
• To aid practicing pediatricians and neonatologists in making evidence-based decisions regarding hypoglycemia management.
• To address the controversies and weak evidence base surrounding current guidelines.

Main Methods:

• Literature review synthesizing current knowledge on neonatal hypoglycemia.
• Analysis of physiological mechanisms, diagnostic criteria, and therapeutic options.
• Discussion of risk factors, neurodevelopmental implications, and legal considerations.

Main Results:

• Neonatal hypoglycemia definition and treatment thresholds vary significantly based on postnatal age and clinical context.
• The exact blood glucose levels and duration causing neurological damage remain unclear.
• Early breastfeeding and oral dextrose gel are potential strategies to mitigate hypoglycemia and NICU admissions, though evidence is limited.

Conclusions:

• Standardized protocols for neonatal hypoglycemia diagnosis and management are crucial to prevent adverse neurodevelopmental outcomes.
• Further research is needed to establish stronger evidence for current guidelines and therapeutic interventions.
• Rational decision-making in managing neonatal hypoglycemia requires a thorough understanding of the available, albeit often limited, evidence.